Routine Blood Hemoglobin Levels Linked to Long-Term Dementia Risk
Routine blood tests measuring hemoglobin levels may offer early prognostic clues regarding a person's long-term risk of developing dementia, according to a large-scale study presented at the ECNP Congress in Munich and published in the Journal of Alzheimer's Disease. Researchers analyzed health records from 316,542 South Korean adults aged 40 and older who underwent national health screenings in 2004 and 2005, tracking new dementia diagnoses through 2019.
Multivariate analysis of dementia risk in Korean national health screening cohorts controlled for smoking status, body mass index, household income, baseline cognitive state, sex, disability, depression, hypertension, diabetes, and dyslipidemia.
Participants were divided into five cohorts based on hemoglobin levels. Individuals in the lowest 20% of hemoglobin levels exhibited a 16% higher risk of all-cause dementia compared to the reference group with the lowest dementia rates, while those in the highest 20% experienced a 7% elevated risk. The association varied by specific neurological conditions. For Alzheimer's disease, heightened risk was concentrated primarily among individuals in the lowest hemoglobin quintile, who faced a 14% greater risk.
Vascular Dementia and Gender Variations
The pattern proved more complex for vascular dementia, which arises from restricted cerebral blood flow. Participants in the lowest hemoglobin quintile demonstrated a 19% higher risk, whereas those in the highest quintile showed an 18% increased risk. However, the correlation for vascular dementia did not follow a linear gradient across all five cohorts. Furthermore, the statistical association between abnormal hemoglobin levels and subsequent dementia was clearer and more consistent among female participants than among males.
Hemoglobin functions as the oxygen-carrying protein within red blood cells. Low hemoglobin levels typically signify anemia, whereas elevated readings can stem from dehydration, smoking, or underlying cardiopulmonary conditions. Lead researcher Dr. Hyun Soo Kim of Dong-A University College of Medicine emphasized that the findings do not prove a direct causal relationship. Instead, abnormal hemoglobin acts as a visible clinical marker reflecting broader systemic vulnerability affecting long-term brain health.
Clinical Interpretation and Expert Caveats
Independent specialists urged caution in interpreting the observational data. Dr. Lindsey Sinclair of the University of Southampton noted that while the study reinforces the recognized link between systemic physical health and neurological integrity, further research across diverse populations is necessary.
Researchers stressed that patients should not interpret the findings as an indication to self-prescribe iron supplements or attempt to manipulate hemoglobin levels to prevent cognitive decline. Unexplained abnormal blood counts warrant professional clinical evaluation to identify underlying pathology rather than serving as an isolated preventative target.
What an observed dementia link means
An association between haemoglobin readings and dementia risk is not proof that changing a person's haemoglobin will prevent dementia. Anaemia, chronic illness, nutrition and other conditions can influence both a blood-test result and long-term health. The important methodological questions are how the study defined low and high haemoglobin, which factors it adjusted for and whether results were consistent across age groups. Patients should not alter iron intake or seek a target haemoglobin level on the strength of an observational headline. A clinician can interpret an abnormal blood count in the context of symptoms and medical history.